Webinar: Novel co-creation for novel trial design How co-creation with differs within DCTs and Traditional trials 26th Jan 2022


Engaging with participants to influence clinical research design is the standard for industry innovators. Our ability to gain participant feedback in design, throughout the life of the study and at close-out is a way our industry can “be,” not just “say,” we are patient-centric.

Accelerate recruitment, increase retention, and ensure diversity with DCT optimized co-creation 

Engaging with participants to influence clinical research design is the standard for industry innovators. Our ability to gain participant feedback in design, throughout the life of the study and at close-out is a way our industry can “be,” not just “say,” we are patient-centric.

This approach is available to our industry and being utilized today to enhance traditionally designed and decentralized research studies. The benefits are obvious, but the solutions have historically been challenging to collect, listen to and incorporate. That is now changing via the intersection of participant engagement science, decentralization, and digital technologies.

This session will explore how you can utilize this approach to differentiate your research study and be patient-centric.

Join LEO Pharma, Sanofi, THREAD, Modus Outcomes, People with Empathy (patient advocacy), and InVibe as they discuss:

•            How co-creation differs in traditional design versus decentralized clinical studies

•            Operational approaches to gain and implementing feedback in design

•            How to gather and implement iterative patient feedback in ongoing trial design

•            Balance patient, caregiver, and healthcare system requirements to ensure retention and diversity

•            Understand how patients value and assess novel endpoints in studies

comments powered by Disqus